Skip to main content
logo
Nasus Pharma Ltd. (NSRX)
Nasus Pharma will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$10.00 - $12.00
Shares Offered
Unknown
Deal Size
Unknown

Nasus Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 Dec '24 Dec '23
Cash & Equivalents
0.310.21
Cash & Cash Equivalents
0.310.21
Cash Growth
48.09%-
Other Current Assets
0.150.23
Total Current Assets
0.460.44
Other Long-Term Assets
0.260
Total Long-Term Assets
0.260
Total Assets
0.720.44
Accounts Payable
0.650.66
Current Debt
1.82.46
Other Current Liabilities
1.481.13
Total Current Liabilities
3.934.24
Total Liabilities
3.934.24
Total Debt
1.82.46
Debt Growth
-26.66%-
Retained Earnings
-12.66-11.13
Shareholders' Equity
-3.21-3.8
Net Cash (Debt)
-1.49-2.25
Working Capital
-3.47-3.8
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).